publication venue for
- Treatment of metastatic non-small cell lung cancer.. 8. 1996
- New imaging modalities to distinguish rare uterine mesenchymal cancers from benign uterine lesions. 2021
- Advances in immunotherapy in multiple myeloma. 2017
- Stop and go: hematopoietic cell transplantation in the era of chimeric antigen receptor T cells and checkpoint inhibitors. 2017
- Update in germ cell tumours. 2015
- Harnessing the immune system for cancer therapy. 2014
- Management of advanced uterine leiomyosarcoma. 2014
- The role of high-dose chemotherapy in the management of germ cell tumors. 2014
- Pathology of lymphoma in HIV. 2013
- Allogeneic hematopoietic stem cell transplantation for multiple myeloma: curative but not the standard of care. 2012
- Current treatment of acute myeloid leukemia. 2012
- Treatment of nonsmall cell lung cancer: overcoming the resistance to epidermal growth factor receptor inhibitors. 2012
- Role of tracheal resection in thyroid cancer. 2012
- Current status of allogeneic transplantation for aggressive non-Hodgkin lymphoma. 2011
- Clinical and molecular approaches to well differentiated and dedifferentiated liposarcoma. 2011
- Prophylaxis and treatment of dermatologic adverse events from epidermal growth factor receptor inhibitors. 2011
- Postchemotherapy surgery for germ cell tumors of the testis. 2011
- Epidermal growth factor receptor inhibitors in oncology. 2010
- Controversies in the treatment of Burkitt lymphoma in AIDS. 2010
- The management of resectable and unresectable liver metastases from colorectal cancer. 2010
- Update on gemcitabine and docetaxel combination therapy for primary and metastatic sarcomas. 2010
- Utilization of positron emission tomography in the management of patients with sarcoma. 2009
- Histone deacetylase inhibitors in cancer therapy. 2008
- The use of second-generation thrombopoietic agents for chemotherapy-induced thrombocytopenia. 2008
- Antiangiogenic therapy in nonsmall cell lung cancer. 2008
- Advances in the molecular characterization of Philadelphia-negative chronic myeloproliferative disorders. 2007
- Management of peripheral T-cell non-Hodgkin's lymphoma. 2007
- Current topics in melanoma. 2007
- Early melanoma diagnosis: a success story that leaves room for improvement. 2007
- Update in HIV lymphoma. 2006
- Health economics: can we afford an unrestricted use of new biological agents in gastrointestinal oncology? 2005
- Treatment of malignant thymoma. 2005
- Pheochromocytoma and functional paraganglioma. 2005
- Update in HIV-associated lymphoma. 2004
- High-dose therapy with autologous stem cell rescue for pediatric sarcomas. 2004
- Role of surgery in patients with stage IV melanoma. 2004
- Recent developments in the biology and therapy of T-cell and natural killer-cell lymphomas. 2003
- Update in Kaposi sarcoma. 2003
- Predictive variables detailing the recurrence rate of soft tissue sarcomas. 2003
- The role of surgery for patients with metastatic melanoma. 2002
- Biology and management of mantle cell lymphoma. 2001
- Adjuvant therapy for noncolorectal cancers. 2001
- Chronic myelogenous leukemia. 2001
- Role of tumor necrosis factor-alpha inhibition with inflixiMAB in cancer therapy and hematopoietic stem cell transplantation. 2000
- Radiation therapy in the treatment of lymphoma. 1999
- Radioimmunotherapy for lymphoma. 1999
- Virus-associated lymphomas. 1999
- Genetic predisposition to skin cancer. 1999
- Reinventing bone marrow transplantation: reducing toxicity using nonmyeloablative, preparative regimens and induction of graft-versus-malignancy. 1999
- Chemotherapy in gynecologic cancer. 1998
- Economic considerations in the care of patients with head and neck malignancies. 1997
- Melanoma epidemiology. 1997
- Neoadjuvant therapy for upper gastrointestinal tract cancers. 1996
- Multidrug resistance proteins and other drug transport-related resistance to natural product agents. 1995
- Radiation therapy for breast cancer. 1995
- Chemotherapy for recurrent disease and combined modality therapies for head and neck cancer. 1995
- Prostate cancer in the era of prostate-specific antigen. 1995
- Radiation therapy for breast cancer. 1994
- Prostate cancer: how can a common disease be so controversial? 1994
- Immunotherapy for acute leukemias. 1994
- Radiation therapy for breast cancer. 1993
- Systemic adjuvant therapy for breast cancer. 1993
- Biologic aspects of AIDS-associated non-Hodgkin's lymphoma. 1993
- Incorporating tumor biology into therapy for prostate cancer. 1993
- Radiation therapy for breast cancer. 1992
- Prostatic cancer: are we closer to rational treatment selection? 1992
- Chronic myeloid leukemia. 1992
- Radiotherapy in breast cancer. 1991
- Therapy for colorectal cancer. 1991
- Prostatic cancer: where do we go from here? 1991
- Radiotherapy in the management of primary and advanced breast cancer. 1990
- Predicting biologic potential in prostate cancer. 1990
- Monoclonal antibodies for the treatment of cancer: therapeutic strategies. 1989
- Radiotherapy in the management of primary and advanced disease. 1989
- Radiation therapy in gynecologic cancer. 1989